ArticleFrontiers in immunology2023

IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models.

Hongtai Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.